During the past decade, Ospedale San Paolo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Paolo" #1 collaborator was "Heart Care Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Paolo" are "Acute Myocardial Infarction" (1 trials), "Atrial Fibrillation" (1 trials), "Heart Failure" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Ospedale San Paolo" in a lesser frequency.

Most popular intervention types in "Ospedale San Paolo" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Beta blocker" (1 trials), "Cyclosporine A" (1 trials), "Edoxaban" (1 trials), "Placebo" (1 trials) and "Rosuvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Paolo" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale San Paolo". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ospedale San Paolo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Paolo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".